Cellular receptors for plasminogen activators: Recent advances

Trends in Cardiovascular Medicine

Volumn 7, Issue 7, 1997, Pages 227-234

  Ellis, Vincent ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

CELL MIGRATION; ENZYME ACTIVITY; ENZYME BINDING; EXTRACELLULAR MATRIX; FIBRINOLYSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; SHORT SURVEY; VASCULAR SMOOTH MUSCLE;

EID: 0030671406     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00084-4     Document Type: Review

References (54)

1. Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Danø K The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem. 266:1991;7842-7847.
2. Behrendt N, Rønne E, Danø K A novel, specific pro-urokinase complex on monocyte-like cells, detected by transglutaminase-catalyzed cross-linking. FEBS Lett. 336:1993;394-396.
3. Besser D, Verde P, Nagamine Y, Blasi F Signal transduction and the u-PA/u-PAR system [Review]. Fibrinolysis. 10:1996;215-237.
4. Blasi F, Vassalli J-D, Danø K Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors [Review]. J Cell Biol. 104:1987;801-804.
5. 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med. 181:1995;1381-1390.
6. Bugge TH, Flick MJ, Daugherty CC, Degen JL Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9:1995;794-807.
7. Bugge TH, Suh TT, Flick MJet al. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem. 270:1995;16,886-16,894.
8. Bugge TH, Flick MJ, Danton MJet al. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci USA. 93:1996;5899-5904.
9. Carmeliet P, Schoonjans L, Kieckens Let al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368:1994;419-424.
10. Carmeliet P, Moons L, Ploplis VA, Plow EF, Collen D Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest. 99:1997;200-208.
11. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 67:1990;61-67.
12. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA. 90:1993;5021-5025.
13. Danø K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion [Review]. Fibrinolysis. 8((Suppl 1)):1994;189-203.
14. Deng G, Curriden SA, Wang SJ, Rosenberg S, Loskutoff DJ Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol. 134:1996;1563-1571.
15. Ellis V Functional analysis of the cellular receptor for urokinase in plasminogen activation. J Biol Chem. 271:1996;14,779-14,784.
16. Ellis V, Danø K Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation: a mechanistic model for receptor-mediated plasminogen activation. J Biol Chem. 268:1993;4806-4813.
17. Ellis V, Whawell SA: 1997. Vascular smooth muscle cells potentiate plasmin generation by both orikinase and tissue plasminogen activator dependent mechanisms: evidence for a specific tPA receptor on these cells. Blood (in press).
18. Ellis V, Scully MF, Kakkar VV Plasminogen activation initiated by single-chain urokinase-type plasminogen activator: potentiation by U937 monocytes. J Biol Chem. 264:1989;2185-2188.
19. Ellis V, Wun T-C, Behrendt N, Rønne E, Danø K Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J Biol Chem. 265:1990;9904-9908.
20. Ellis V, Behrendt N, Danø K Plasminogen activation by receptor-bound urokinase: a kinetic study with both cell-associated and isolated receptor. J Biol Chem. 266:1991;12,752-12,758.
21. Fletcher CM, Harrison RA, Lachmann PJ, Neuhaus D Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. Structure. 2:1994;185-199.
22. Goodson RJ, Doyle MV, Kaufman SE, Rosenberg S High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc Natl Acad Sci USA. 91:1994;7129-7133.
23. Gyetko MR, Todd RF III, Wilkinson CC, Sitrin RG The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest. 93:1994;1380-1387.
24. Gyetko MR, Chen GH, McDonald RAet al. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. J Clin Invest. 97:1996;1818-1826.
25. Hajjar KA, Hamel NM, Harpel PC, Nachman RL Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest. 80:1987;1712-1719.
26. Hajjar KA, Jacovina AT, Chacko J An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II J Biol Chem. 269:1994;21,191-21,197.
27. Hajjar KA, Guevara CA, Lev E, Dowling K, Chacko J Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface: essential role of endonexin repeat 2. J Biol Chem. 271:1996;21,652-21,659.
28. Herbert JM, Lamarche I, Prabonnaud V, Dol F, Gauthier T Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J Biol Chem. 269:1994;3076-3080.
29. Higazi AA, Cohen RL, Henkin J, Kniss D, Schwartz BS, Cines DB Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. J Biol Chem. 270:1995;17,375-17,380.
30. Higazi AA, Upson RH, Cohen RLet al. Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins. Blood. 88:1996;542-551.
31. Høyer-Hansen G, Rønne E, Solberg Het al. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem. 267:1992;18,224-18,229.
32. Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res. 224:1996;344-353.
33. Lee SW, Ellis V, Dichek DA Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase. J Biol Chem. 269:1994;2411-2418.
34. Nusrat AR, Chapman HA An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J Clin Invest. 87:1991;1091-1097.
35. Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L, Vassalli JD Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol. 122:1993;673-684.
36. Ploug M, Ellis V Structure-function relationships in the receptor for urokinase-type plasminogen activator: comparison to other members of the Ly-6 family and snake venom α-neurotoxins [Review]. FEBS Lett. 349:1994;163-168.
37. Ploug M, Rønne E, Behrendt N, Jensen AL, Blasi F, Danø K Cellular receptor for urokinase plasminogen activator: carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem. 266:1991;1926-1933.
38. Ploug M, Plesner T, Rønne Eet al. The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood. 79:1992;1447-1455.
39. Ploug M, Ellis V, Danø K Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate: evidence for a hydrophobic binding site exposed only on the intact receptor. Biochemistry. 33:1994;8991-8997.
40. Ploug M, Rahbek-Nielsen H, Ellis V, Roepstorff P, Danø K Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane: evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction. Biochemistry. 34:1995;12,524-12,534.
41. Plow EF, Felez J, Miles LA Cellular regulation of fibrinolysis [Review]. Thromb Haemost. 66:1991;32-36.
42. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 15:1996;1572-1582.
43. Rømer J, Bugge TH, Pyke Cet al. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med. 2:1996;287-292.
44. Russell ME, Quertermous T, Declerck PJ, Collen D, Haber E, Homcy CJ Binding of tissue-type plasminogen activator with human endothelial cell monolayers: characterization of the high affinity interaction with plasminogen activator inhibitor-1. J Biol Chem. 265:1990;2569-2575.
45. Sitrin RG, Todd RF III, Petty HRet al. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest. 97:1996;1942-1951.
46. Stahl A, Mueller BM The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol. 129:1995;335-344.
47. 3 binding to vitronectin. Nature. 383:1996;441-443.
48. Tsirka SE, Gualandris A, Amaral DG, Strickland S Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature. 377:1995;340-344.
49. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci. 17:1997;543-552.
50. 125I-tissue plasminogen activator binding to cerebellar granule neurons. J Cell Biol. 109:1989;265-271.
51. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem. 269:1994;32,380-32,388.
52. Wei Y, Lukashev M, Simon DIet al. Regulation of integrin function by the urokinase receptor. Science. 273:1996;1551-1555.
53. Xue W, Kindzelskii AL, Todd RF III, Petty HR Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J Immunol. 152:1994;4630-4640.
54. 5-directed cell migration. J Biol Chem. 271:1996;29,393-29,399.